Healthcare
Relevium Technologies Inc.(RLLVF)
Live Price
Offline$0.006
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
- Market Cap
- —
- Revenue Growth
- -69.3%
- EPS Growth
- +30.2%
- Dividend Yield
- 0.0%
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Relevium Technologies Inc. (RLLVF) is a Healthcare stock with listed on OTC. The stock last traded around $0.01 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -69.3%, EPS growth of +30.2%, a dividend yield of 0.0%. What stands out right now is revenue -69.3%, EPS +30.2%, free cash flow +94.1% with operating margin -161.5% and ROIC 88.9%. Valuation is more restrained than many high-expectation growth names at price/sales 2.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RLLVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-69.3% vs +7.6% peer median
Operating Margin
Below sector median
-161.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -69.3% and EPS is at +30.2%, with operating margin around -161.5%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RLLVF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RLLVF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RLLVF and SPY.
Company Overview
Relevium Technologies Inc.
Other OTC
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
- Leadership
- Aurelio Useche
- IPO Date
- Nov 24, 2017
- Street Address
- 1000 Sherbrooke Street West
- Mailing
- Montreal, QC, H3A 3G4
- Region
- Montreal, QC, CA
- Reporting Currency
- USD
- Investor Line
- +1 514 815 8473
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 2.9
- Price/Book
- —
Growth
- Revenue
- -69.3%
- EPS
- +30.2%
- Free Cash Flow
- +94.1%
Profitability
- Gross Margin
- 45.4%
- Operating Margin
- -161.5%
- Net Margin
- -587.6%
- ROE
- 221.4%
- ROIC
- 88.9%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.